2-aminobicyclo(2,2,1)heptane-2-carboxylic acid has been researched along with Animal Mammary Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukumoto, S; Hanazono, K; Iwano, H; Kadosawa, T; Komatsu, T; Uchide, T; Ueno, H | 1 |
1 other study(ies) available for 2-aminobicyclo(2,2,1)heptane-2-carboxylic acid and Animal Mammary Carcinoma
Article | Year |
---|---|
L-type amino acid transporter 1 (LAT1): a new therapeutic target for canine mammary gland tumour.
Topics: Amino Acids, Cyclic; Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Large Neutral Amino Acid-Transporter 1; Mammary Neoplasms, Animal; Melphalan; Real-Time Polymerase Chain Reaction | 2013 |